Both NHS and private staff were paid the sum for consultancies,
sponsorships and other dealings with drug businesses in 2012. The ABPI
said it released the figures as part of its “on-going transparency
drive”.
The money was paid to medics for “attending medical education
events, support such as training and development, as well as fees for
services such as speaking engagements to share good clinical practice
and participation in advisory boards,” a spokesman said.
Leaders of the medical profession and pharmaceutical industries are
examining whether doctors paid by drug companies should declare their
dealings on a public register.
Disclosure of payments would be a “significant step” towards greater
transparency, according to the Ethical Standards in Health and Life
Sciences Group.